| scholarly article | Q13442814 |
| P2093 | author name string | Jaime Mella-Raipán | |
| César Morales-Verdejo | |||
| David Pessoa-Mahana | |||
| Santiago Hernández-Pino | |||
| P2860 | cites work | An effort to discover the preferred conformation of the potent AMG3 cannabinoid analog when reaching the active sites of the cannabinoid receptors. | Q51501546 |
| Design, synthesis, and pharmacological characterization of indol-3-ylacetamides, indol-3-yloxoacetamides, and indol-3-ylcarboxamides: potent and selective CB2 cannabinoid receptor inverse agonists. | Q51759390 | ||
| Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish | Q55871276 | ||
| [Medical use of cannabis through history] | Q77395302 | ||
| Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations | Q24309438 | ||
| Cannabinoid receptor localization in brain | Q24558751 | ||
| Is lipid signaling through cannabinoid 2 receptors part of a protective system? | Q24633122 | ||
| Iterative partial equalization of orbital electronegativity—a rapid access to atomic charges | Q28096294 | ||
| Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism | Q28252850 | ||
| Indol-3-ylcycloalkyl ketones: effects of N1 substituted indole side chain variations on CB(2) cannabinoid receptor activity | Q28265080 | ||
| Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study | Q28273200 | ||
| Beware of q2! | Q28842863 | ||
| Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study | Q29615905 | ||
| Design, synthesis, binding and docking-based 3D-QSAR studies of 2-pyridylbenzimidazoles--a new family of high affinity CB1 cannabinoid ligands. | Q30612575 | ||
| Cannabinoid receptors and the regulation of immune response | Q34099012 | ||
| The cannabinoid receptors. | Q34159121 | ||
| Nonpsychotropic cannabinoid receptors regulate microglial cell migration. | Q34179008 | ||
| Cannabinoid receptors as therapeutic targets. | Q34482964 | ||
| Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. | Q34602111 | ||
| The application of 3D-QSAR studies for novel cannabinoid ligands substituted at the C1' position of the alkyl side chain on the structural requirements for binding to cannabinoid receptors CB1 and CB2. | Q34631048 | ||
| Indol-3-yl-tetramethylcyclopropyl ketones: effects of indole ring substitution on CB2 cannabinoid receptor activity | Q34756953 | ||
| Cannabinoid receptors: where they are and what they do. | Q34772274 | ||
| CB(1) receptor antagonism: biological basis for metabolic effects | Q34840194 | ||
| The endocannabinoid system and its therapeutic exploitation | Q35876026 | ||
| Endocannabinoid control of food intake and energy balance | Q36108722 | ||
| Effects of cannabinoids on the immune system and central nervous system: therapeutic implications | Q37010119 | ||
| Cannabis: pharmacology and toxicology in animals and humans | Q41278775 | ||
| Cannabinoid-receptor expression in human leukocytes | Q41553271 | ||
| CB1 receptor-independent actions of SR141716 on G-protein signaling: coapplication with the mu-opioid agonist Tyr-D-Ala-Gly-(NMe)Phe-Gly-ol unmasks novel, pertussis toxin-insensitive opioid signaling in mu-opioid receptor-Chinese hamster ovary cells | Q42453820 | ||
| Evaluation of the membrane permeability (PAMPA and skin) of benzimidazoles with potential cannabinoid activity and their relation with the Biopharmaceutics Classification System (BCS). | Q42796713 | ||
| CoMFA and CoMSIA analyses on 1,2,3,4-tetrahydropyrrolo[3,4-b]indole and benzimidazole derivatives as selective CB2 receptor agonists | Q43154543 | ||
| Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes | Q45076771 | ||
| Three-dimensional QSAR of human immunodeficiency virus (I) protease inhibitors. 1. A CoMFA study employing experimentally-determined alignment rules | Q45776986 | ||
| Three-dimensional quantitative structure-activity relationship of human immunodeficiency virus (I) protease inhibitors. 2. Predictive power using limited exploration of alternate binding modes | Q45781093 | ||
| A computational study on cannabinoid receptors and potent bioactive cannabinoid ligands: homology modeling, docking, de novo drug design and molecular dynamics analysis. | Q45964324 | ||
| 3D-QSAR studies of arylpyrazole antagonists of cannabinoid receptor subtypes CB1 and CB2. A combined NMR and CoMFA approach | Q46899027 | ||
| Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins | Q47746759 | ||
| Role of cannabinoid CB1 receptors and Gi/o protein activation in the modulation of synaptosomal Na+,K+-ATPase activity by WIN55,212-2 and delta(9)-THC. | Q48098989 | ||
| Strategic approaches to drug design. I. An integrated software framework for molecular modelling | Q50149089 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cannabinoid receptor | Q421237 |
| cannabinoids | Q422936 | ||
| CNR2 | Q17907844 | ||
| P304 | page(s) | 2842-2861 | |
| P577 | publication date | 2014-03-05 | |
| P1433 | published in | Molecules | Q151332 |
| P1476 | title | 3D-QSAR/CoMFA-based structure-affinity/selectivity relationships of aminoalkylindoles in the cannabinoid CB1 and CB2 receptors | |
| P478 | volume | 19 |
| Q47951311 | 2D-QSAR and 3D-QSAR/CoMSIA Studies on a Series of (R)-2-((2-(1H-Indol-2-yl)ethyl)amino)-1-Phenylethan-1-ol with Human β₃-Adrenergic Activity |
| Q58696615 | Discovery of High-Affinity Cannabinoid Receptors Ligands through a 3D-QSAR Ushered by Scaffold-Hopping Analysis |
| Q36257797 | Exhaustive CoMFA and CoMSIA analyses around different chemical entities: a ligand-based study exploring the affinity and selectivity profiles of 5-HT1A ligands |
| Q30241053 | Focus on cannabinoids and synthetic cannabinoids |
| Q26829111 | Minireview: From the bench, toward the clinic: therapeutic opportunities for cannabinoid receptor modulation |
| Q59794173 | Molecular Modeling and Design Studies of Purine Derivatives as Novel CDK2 Inhibitors |
| Q48075432 | New insights into PDE4B inhibitor selectivity: CoMFA analyses and molecular docking studies |
| Q91602718 | Receptor Binding Affinities of Synthetic Cannabinoids Determined by Non-Isotopic Receptor Binding Assay |
| Q64906019 | Three-Dimensional Quantitative Structure-Activity Relationships (3D-QSAR) on a Series of Piperazine-Carboxamides Fatty Acid Amide Hydrolase (FAAH) Inhibitors as a Useful Tool for the Design of New Cannabinoid Ligands. |
Search more.